University of California San Francisco
A team of epilepsy specialists at UC San Francisco has developed a method to predict 24-hour seizure risk. The discovery, which may be scalable to large numbers of patients, could help to improve the quality of life for the 2.9 million Americans living with the daily uncertainties of epilepsy.
Acute hepatic porphyria (AHP) is a rare genetic disease with symptoms that overlap with many other conditions, making it extremely challenging to diagnose. Its symptoms mostly affect women with severe, sometimes life-threatening attacks that include abdominal pain, nausea, vomiting, limb weakness and anxiety. It can take up to 15 years to properly diagnose, leading to worsening symptoms and, in some cases, irreversible organ damage.